gl1 tirzepatide Molecular structure of and the dual activation mechanism of Tirzepatide (GLP-1 / GIP)
Description
At the lowest dose studied (5 mg), average weight loss was around 15 percent
Its important to know that compounded GLP-1 medications arent FDA-approved, and the FDA hasnt reviewed them for safety, quality, or how well they work
People at risk for diabetic retinopathy are advised to eat a healthy diet, quit smoking if they smoke, and get regular moderate exercise
All three tirzepatide doses were found to be superior to placebo for both outcomes (Figure 2)
